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Introduction 
Differential diagnosis of an intracardiac mass in the tricus-
pid valve after valvular surgery includes thrombosis, tumor, 
and vegetation, among others. Normal tissue such as fatty 
material and pectinate muscle surrounding the tricuspid an-
nulus also may appear as a pseudo-tumor.1) In our case, be-
cause the patient had undergone annuloplasty, thrombosis was 
suspected as most likely and therefore thrombolytic therapy 
was instituted.2) Because the size of the cardiac mass did not 
change, however, we finally chose a surgical method and the 
mass was found to be a myxoma. To our knowledge, this is 
first reported case of tricuspid valve myxoma in Korea.
Case
In November 2009, a 55-year-old man (who had smoking 
as a risk factor) was admitted to the hospital with progressive 
resting dyspnea. On physical examination, the patient was 
dyspneic and tachypneic. His jugular veins were distended. 
Initial laboratory work-up, including complete blood count, 
liver function tests, and cardiac enzyme level determination 
did not reveal any abnormality. He had an abnormal chest ra-
diograph which showed cardiomegaly and a marked pulmo-
nary trunk, and electrocardiogram reflected right ventricular 
strain pattern with normal sinus rhythm (Fig. 1). NT-pro BNP 
level was 5,592 pg/mL (normal: < 198 pg/mL), and D-dimer 
level was 2,296 ng/mL (normal: < 500 ng/mL). Transthoracic 
echocardiography (TTE) revealed right cardiac dysfunction 
with elevated right ventricular systolic pressure (RVSP). Pul-
monary embolism was suspected and chest 3-dimensional 
computed tomography (3D CT) with contrast enhanced for 
pulmonary embolism showed a massive pulmonary thrombo-
embolism (Fig. 2). No deep vein thrombosis in venous Dop-
pler for the lower extremities or hypercoagulability in the 
laboratory test was apparent. Although the patient was he-
modynamically stable, hypoxemia was noticed in arterial 
blood gas analysis (pH = 7.493, pCO2 = 27.9 mm Hg, pO2 = 
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A 55-year-old man with massive pulmonary thromboembolism underwent thrombolysis, pulmonary artery embolectomy and 
tricuspid annuloplasty. Nine months later, a mobile echogenic intra-cardiac mass was found in the tricuspid valve. Because the 
patient had undergone annuloplasty, thrombosis was suspected as the most likely diagnosis and thrombolytic therapy was 
instituted. However, the size of the cardiac mass did not change and after surgical excision the mass was found to be a myxoma. 
Cardiac valvular tumors are uncommon and when they occur they are usually slow growing fibroelastomas. In this case, the rapid 
growing cardiac myxoma on the tricuspid valve was found after the occurrence of pulmonary thromboembolism. To our 
knowledge, this is first reported case of tricuspid valve myxoma in Korea.
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61.9 mm Hg). Therefore he was thrombolysed with recombi-
nant tissue plasminogen activator and experienced a rapid im-
provement in oxygenation.3) As follow-up, a second echocar-
diography and chest 3D CT was performed 7 days later. TTE 
showed impairment in right ventricular function even though 
RVSP was reduced from 119 to 96 mm Hg and a second CT 
showed a partially resolved status. There was multifocal exten-
sive pulmonary thromboembolism in both pulmonary arteries 
(Fig. 3). Because further treatment was required to reduce pul-
monary hypertension, we performed open pulmonary embo-
lectomy with removal of thrombus from both pulmonary ar-
teries, and De Vega’s tricuspid annuloplasty to correct severe 
tricuspid valve regurgitation. The patient experienced no 
postoperative complications and made a satisfactory recovery. 
At 2 weeks after surgery, his TTE findings showed improve-
ment in right heart function and RVSP (97 →	47 mm Hg). 
The patient was discharged from the hospital on warfarin. 
Nine months later, however, we found a mobile echogenic in-
tra-cardiac mass (1.49 × 2.2 cm sized) at follow-up. The mass 
was attached to the septo-posterior leaflet portion of the tri-
Fig. 1. A: Chest X-ray showed cardiomegaly with right atrial enlargement and a prominent pulmonary trunk. B: Electrocardiogram showed 
characteristic features of RV strain with prominent S wave in lead I, Q wave in lead III, with T-wave inversion in lead III. RV: right ventricle.
A B
Fig. 2. A: Chest CT scanning detected a large thrombus in the right pulmonary artery. B: D-shaped LV was shown. C: Vmax was 4.96 m/s. Estimated 
right ventricular systolic pressure was 119 mm Hg (assumed right atrial pressure = 20 mm Hg, inferior vena cava dilatation and plethora was found). 
LV: left ventricle.
Fig. 3. A: A second computed tomogram showed a partially resolved multifocal extensive pulmonary thrombus. B: D-shaped LV remained after 
thrombolysis. C: Vmax was 4.46 m/s. After thrombolysis, estimated right ventricular systolic pressure was slightly reduced. LV: left ventricle.
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cuspid valve and protruded to the ventricular side. For differen-
tial diagnosis, trans-esophageal echocardiography was carried 
out and revealed a mobile mass attached to the annuloplasty 
groove (Fig. 4). Also his prothrombin time was occasionally 
inappropriate fluctuating from 1.58 to 2.65 for 9 months. 
Based on a suspicion of thrombus formation, we decided to 
do thrombolysis with tissue plasminogen activator (TPA). 
TPA (Alteplase®) was infused 100 mg, 10 mg as a bolus and 
40 mg over 2 hours followed by 50 mg over 5 hours.2) How-
ever, the mass did not respond to thrombolysis, and the pa-
tient underwent surgery. Gross examination of the operative 
specimen revealed a polypoid mass with smooth surfaces; his-
tological examination showed a myxoid matrix composed of 
an acid-mucopolysaccharide - rich stroma and embedded po-
lygonal cells in hematoxylin and eosin stain, consistent with 
myxoma (Fig. 5).
Discussion
Thrombosis is first suspected when an intracardiac mass is 
observed in the tricuspid valve after valvular surgery. Patients 
with a right atrial thrombus have several therapeutic options. 
For the patient at high risk for surgery, anticoagulation with 
heparin followed by an ongoing regimen of warfarin may be 
the treatment of choice.4) Thrombolytic therapy is also report-
ed to be successful in some patients,5) although the possibility 
of pulmonary embolism caused by a fragmented thrombus 
due to thrombolytic therapy is a serious concern. In our case, 
given the patient’s previous history of valvuloplasty, the valvu-
lar mass shown in TTE was suspected to be thrombus, so 
thrombolytic therapy was performed.2) After thrombolytic ther-
apy, the size of the valvular mass did not change. We needed to 
exclude the possibility of other types of cardiac tumor and 
therefore decided to examine by surgical excision. The valvu-
lar mass was found to be myxoma. The differential diagnoses 
of intraatrial masses include atrial myxoma, thrombus related 
to atrial fibrillation, vegetation, metastatic tumors, and pri-
mary benign or malignant tumors.6) Although a mass usually 
shows up differently in an echocardiographic image, it is diffi-
cult to discriminate between thrombus and tumor. However, 
in our case it was difficult to make an accurate preoperative di-
agnosis. The patient underwent surgical excision of the tricus-
pid valvular mass. Histopathology allowed diagnosis of the 
Fig. 4. A and B: Parasternal short axis view and apical four-chamber view. There was no visible mass in the immediate postoperative image. C and 
D: Parasternal short axis view and apical four-chamber view. There was a visible mass (arrow) with stalk 9 months later. E and F: Mid-esophageal RV 
inflow-outflow view in 64 degrees and mid-esophageal RV inflow view in 116 degrees. An intracardiac mass (arrow) was obvious (size: 2.2 × 1.5 cm2). 
After the 5th day of thrombolysis, the mass size remained unchanged. RA: right atrium, RV: right ventricle, RVOT: right ventricular outflow track, LA: 
left atrium, LV: left ventricle.
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mass as a tricuspid valvular myxoma. 
Myxomas are the most common type of primary benign 
cardiac tumor, accounting for 50% of all primary cardiac tu-
mors. Myxomas may develop in any chamber of the heart: ap-
proximately 75% of myxomas develop in the left atrium, 23% 
in the right atrium, and the remaining 2% in the ventricles. 
Primary tumors of the cardiac valves and chordae are uncom-
mon. When they do occur, they are usually slow-growing fi-
broelastomas which manifest after several years.7) The interest-
ing aspect of our case was the rapid growing cardiac myxoma 
which became apparent on the tricuspid valve within 9 months 
after tricuspid annuoplasty. To our knowledge, this is first re-
ported case of tricuspid valve myxoma in Korea.
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Fig. 5. A: After right atrial opening, photograph showed a polypoid mass attached between annulus and tricuspid valve. B: After excision, mass size 
was similar to echocardiographically measured size (resected tumor size was approximately 2.5 × 1.5 cm2). C: Histological findings with Hematoxylin-
Eosin staining. Histological examination of the mass revealed that it was composed of scattered small oval or stellate cells with abundant myxoid 
matrix, consistent with a diagnosis of nonmalignant cardiac myxoma. The tumor was hypocellular with prominent myxoid stroma and thick walled 
blood vessels (arrows, × 100). D: The tumor cells were elongated or stellate (arrowheads). They had round to elongated nuclei and eosinophilic 
cytoplasm. Lymphoplasma cells and histiocytes are present (× 400).
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